prevention, detection and treatment of aml relapse after allo-sct
Published 5 years ago • 259 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
2:25
optimizing haplo-sct for the treatment of aml
-
3:14
determining the optimal frontline treatment of aml
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
1:19
new treatments for aml
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
3:15
using targeted therapies to optimize transplant outcomes in aml
-
2:43
diagnostic tools for aml
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
3:24
molecular profiling to determine treatment for all and aml
-
11:42
aml treatment: what does the data say?
-
11:19
immunotherapy for aml & all
-
11:35
optimization of standard aml treatment: apl advances, adverse cytogenetics & post-remission therapy
-
1:24
mechanisms of resistance to flt3 inhibitors in aml and strategies to overcome this
-
1:33
sorafenib as maintenance therapy for patients with transplant-ineligible or post-allosct aml
-
2:09
advances in the management of fit adults with aml
-
0:51
key unmet needs in the treatment of immune-mediated ttp